IBBQ Performance — Invesco Nasdaq Biotechnology ETF
Data updated: 2026-07-28
IBBQ returned +5.17% year to date and +47.63% over one year to May 2026. Annualised returns are +14.52% over 3 years and +4.03% over 5 years. The fund beat its Health Care Equity category average: $100 invested three years ago grew to $150, against $131 for the category, and to $148 over one year, against $129. Volatility over the past three years was 16.13% a year. In the 12 months to May 2026 the fund took in a net $15.2M, and assets reached $67.37M.
IBBQ Growth of $100
What $100 invested in Invesco Nasdaq Biotechnology ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | IBBQ | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $148 | $129 |
| 3 years (Jun 2023 – May 2026) | $150 | $131 |
| 5 years (Jun 2021 – May 2026) | $122 | $116 |
IBBQ Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.17% |
| 1 year | +47.63% |
| 3 years (annualised) | +14.52% |
| 5 years (annualised) | +4.03% |
IBBQ Annual Returns
Calendar-year total returns of Invesco Nasdaq Biotechnology ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +5.17% |
| 2025 | +33.36% |
| 2024 | −0.63% |
| 2023 | +4.49% |
| 2022 | −10.24% |
| 2021 (Jun–Dec) | −6.79% |
IBBQ Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.5% | +3.3% | −3.3% | +0.4% | +2.3% | — | — | — | — | — | — | — |
| 2025 | +5.1% | −0.2% | −6.0% | +0.3% | −4.0% | +3.7% | +5.5% | +4.9% | +4.4% | +10.0% | +8.5% | −1.9% |
| 2024 | +0.3% | +1.1% | +0.1% | −6.0% | +5.9% | +3.4% | +6.6% | +0.9% | −2.3% | −2.5% | 0.0% | −7.1% |
| 2023 | +3.5% | −6.5% | +1.3% | +1.5% | −2.6% | +0.2% | +1.3% | −0.3% | −3.8% | −6.6% | +5.0% | +12.9% |
| 2022 | −11.9% | −3.9% | +4.3% | −9.8% | −1.2% | +1.1% | +4.1% | −1.0% | −2.3% | +8.9% | +5.9% | −2.9% |
| 2021 | — | — | — | — | — | +1.2% | −0.2% | +4.1% | −4.8% | −1.9% | −3.9% | −1.2% |
IBBQ Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 16.13%
- 3-year Sharpe ratio: 0.62 (vs 4.5% risk-free rate)
- Best month: +12.90% (Dec 2023)
- Worst month: −7.10% (Dec 2024)
IBBQ Fund Flows
Monthly money in and out of Invesco Nasdaq Biotechnology ETF, from SEC Form N-PORT.
- 12-month net flow: $15.2M
- 12-month gross sales (incl. reinvestments): $37.7M
- Sales ÷ redemptions: 1.68×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $0 | $7.6M | −$7.6M |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $2.1M | $1.8M | $294K |
| Jan 2026 | $15.1M | $7.5M | $7.6M |
| Dec 2025 | $5.7M | $0 | $5.7M |
| Nov 2025 | $10.9M | $0 | $10.9M |
| Oct 2025 | $2.3M | $0 | $2.3M |
| Sep 2025 | $953K | $0 | $953K |
| Aug 2025 | $225K | $0 | $225K |
| Jul 2025 | $438K | $5.6M | −$5.1M |
| Jun 2025 | $0 | $0 | $0 |
IBBQ Assets Under Management
Net assets of Invesco Nasdaq Biotechnology ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $67.37M |
| 2026-02-28 | $75.74M |
| 2025-11-30 | $59.47M |
| 2025-08-31 | $35.78M |
| 2025-05-31 | $35.67M |
| 2025-02-28 | $39.94M |
| 2024-11-30 | $41.08M |
| 2024-08-31 | $38.39M |
| 2024-05-31 | $32.42M |
| 2024-02-29 | $26.17M |
| 2023-11-30 | $16.31M |
| 2023-08-31 | $17.33M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.